当前位置:首页>产品中心>单抗/多抗>Anti-Human FAAH Polyclonal Antibody|抗人FAAH多克隆抗体(靶标:人脂肪酸酰胺水解酶)

Anti-Human FAAH Polyclonal Antibody|抗人FAAH多克隆抗体(靶标:人脂肪酸酰胺水解酶)

  • 货号:RB9THD694014
  • 价格:面议
  • 点击:795
   一键复制产品信息 复制成功!

产品介绍

产品参数

形态Liquid
宿主种属Rabbit
克隆性Polyclonal
抗体亚型IgG
纯化方式Purified by antigen affinity column.
内毒素水平Please contact with the lab for this information.
应用ELISA, IHC, WB
种属反应性Human
靶标Anandamide amidohydrolase 1, EC:3.1.1.-, EC:3.5.1.99, FAAH, FAAH1, Fatty acid ester hydrolase, Fatty-acid amide hydrolase 1, Oleamide hydrolase 1
免疫原E. coli - derived recombinant Human FAAH (Ser71-Ser579).
储存缓冲液0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
产品使用说明ELISA:1:5000-1:20000;IHC:1:50-1:500;WB:1:500-1:2000
登录号O00519
背景信息

Fatty-acid amide hydrolase 1 (FAAH) is a ~63 kDa protein. Catalyzes the hydrolysis of endogenous amidated lipids like the sleep-inducing lipid oleamide ((9Z)-octadecenamide), the endocannabinoid anandamide (N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine), as well as other fatty amides, to their corresponding fatty acids, thereby regulating the signaling functions of these molecules. Hydrolyzes polyunsaturated substrate anandamide preferentially as compared to monounsaturated substrates. It can also catalyze the hydrolysis of the endocannabinoid 2-arachidonoylglycerol (2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycerol). FAAH cooperates with PM20D1 in the hydrolysis of amino acid-conjugated fatty acids such as N-fatty acyl glycine and N-fatty acyl-L-serine, thereby acting as a physiological regulator of specific subsets of intracellular, but not of extracellular, N-fatty acyl amino acids.

1. Wei, BQ. et al. (2006) The Journal of biological chemistry 281, 36569-78. PMID: 17015445
2. Kaczocha, M. et al. (2010) The Journal of biological chemistry 285, 2796-806. PMID: 19926788
3. Giang, DK. et al. (1997) Proceedings of the National Academy of Sciences of the United States of America 94, 2238-42. PMID: 9122178
4. Xie, S. et al. (2010) Chemical research in toxicology 23, 1890-904. PMID: 21049984
备注For research use only
【仅供科学研究使用】

相关产品:
产品名称 点击数
Anti-Human ATR Polyclonal Antibody|抗人ATR多克隆抗体(靶标:人ATM和Rad3相关蛋白激酶) 865
Anti-Human ATM Polyclonal Antibody|抗人ATM多克隆抗体(靶标:人ATM丝氨酸/苏氨酸蛋白激酶) 871
Mouse IgG2a (L234AL235AP329G/LALAPG) Recombinant Isotype Control Antibody|小鼠IgG2a(L234A/L235A/P329G/LALAPG)重组同型对照抗体(靶标:小鼠免疫球蛋白G2a(L234A/L235A/P329G突变体 809
InVivo Plus Anti-Mouse CD152/CTLA4 Antibody|InVivo Plus抗小鼠CD152/CTLA4抗体(靶标:小鼠细胞毒性T淋巴细胞相关蛋白4/CD152) 885
InVivo Plus Mouse IL-10R alpha Antibody(1B1.3A)|InVivo Plus小鼠IL-10Rα抗体(靶标:小鼠白细胞介素10受体α亚基) 1053
InVivo Plus Anti-Mouse CD28 Antibody|InVivo Plus抗小鼠CD28抗体(靶标:小鼠CD28分子) 1151
InVivo Plus Anti-Mouse TIGIT Antibody|InVivo Plus抗小鼠TIGIT抗体(靶标:小鼠T细胞免疫球蛋白和ITIM结构域蛋白) 938
InVivo Plus Anti-Mouse IL-23 p19 Antibody|InVivo Plus抗小鼠IL-23 p19抗体(靶标:小鼠白细胞介素23A/p19亚基) 1129
InVivo Plus Human/Mouse/Rat CD47 Antibody(MIAP410)|InVivo Plus人/小鼠/大鼠CD47抗体(靶标:人/小鼠/大鼠CD47分子) 1079
InVivo Plus Human/Mouse/Rat CCL2/MCP1 Antibody(2H5)|InVivo Plus人/小鼠/大鼠CCL2/MCP1抗体(靶标:人/小鼠/大鼠CC趋化因子配体2/单核细胞趋化蛋白1) 947
InVivo Plus Anti-Mouse Siglec-H Antibody|InVivo Plus抗小鼠Siglec-H抗体(靶标:小鼠Siglec-H) 1240
InVivo Plus Mouse CCR3 Antibody(6S2-19-4)|InVivo Plus小鼠CCR3抗体(靶标:小鼠CC趋化因子受体3) 928
InVivo Plus Anti-Mouse osteopontin/SPP1 Antibody|InVivo Plus抗小鼠骨桥蛋白/SPP1抗体(靶标:小鼠分泌型磷蛋白1/骨桥蛋白) 907
InVivo Plus Anti-Mouse CD16/CD32 Antibody|InVivo Plus抗小鼠CD16/CD32抗体(靶标:小鼠FcγRIII/FcγRII) 1007
InVivo Plus Mouse NKG2D/CD314 Antibody(CX5)|InVivo Plus小鼠NKG2D/CD314抗体(靶标:小鼠杀伤细胞凝集素样受体K1/NKG2D/CD314) 958
InVivo Plus Mouse IgG2a, kappa Isotype Control Antibody|InVivo Plus小鼠IgG2a,κ型同型对照抗体(靶标:小鼠免疫球蛋白G2a,κ轻链型同型对照) 1091
InVivo Plus Human IgG1, lambda Isotype Control Antibody|InVivo Plus人IgG1,λ型同型对照抗体(靶标:人免疫球蛋白G1,λ轻链型同型对照) 952
InVivo Plus Mouse IgG2b, kappa Isotype Control Antibody |InVivo Plus小鼠IgG2b,κ型同型对照抗体(靶标:小鼠免疫球蛋白G2b,κ轻链型同型对照) 1000
Anti-Mouse PD-1 Recombinant Antibody|抗小鼠PD-1重组抗体(靶标:小鼠程序性细胞死亡蛋白1/PD-1) 1287
Research Grade Lunaxafusp|研究级Lunaxafusp(靶标:Lunaxafusp(研究用)) 1205
总计 33037 个记录,共 1652 页,当前第 1642 页 | 第一页 上一页 下一页 最末页
在线客服
  • 销售热线:
  • 15898894496(同微信)
  • 我要留言
  • 周一至周日 9:00-22:30